Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Epstein-Barr Virus Infections: early-phase trial registry
5 of 7 indexed Epstein-Barr Virus Infections trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Epstein-Barr Virus Infections: 7 US clinical trials tracked, 5 recruiting.
Epstein-Barr Virus Infections is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is The Center for the Biology of Chronic Disease, running 1 of these trials.
Enrollment posture brief
Registry condition epstein-barr-virus-infections
OPEN 5 | RECR 71% | LATE 0 | EARLY 6 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)
Epstein-Barr Virus Infections lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Epstein-Barr Virus Infections on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Epstein-Barr Virus Infections is recruiting above its size-band peers.
5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Epstein-Barr Virus Infections trials is spread across many organizations.
The Center for the Biology of Chronic Disease accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Epstein-Barr Virus Infections trials plan to enrol fewer than 100 people.
Median target enrolment is 36 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Epstein-Barr Virus Infections research is mostly interventional.
6 interventional and 1 observational studies make up this index (85.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Marengo Therapeutics
NCT05592626
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
National Cancer Institute (NCI)
NCT03258567
R-MVST Cells for Treatment of Viral Infections
Columbia University
NCT05183490
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
Jessie L. Alexander
NCT06909110
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
New York Medical College
NCT03266653
A Retrospective Chart Review Study of Gene-Eden-VIR/Novirin
The Center for the Biology of Chronic Disease
NCT02715752
Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Baylor College of Medicine
NCT00058604
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Epstein-Barr Virus Infections records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Epstein-Barr Virus Infections trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Epstein-Barr Virus Infections page
7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Epstein-Barr Virus Infections trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Center for the Biology of Chronic Disease sponsors the most Epstein-Barr Virus Infections trials on record, review their full trial history before evaluating a specific study. See The Center for the Biology of Chronic Disease's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Epstein-Barr Virus Infections condition card totals 7 registered trials; most-linked intervention Gene-Eden-VIR/Novirin; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.